To share pharmacoepidemiological learnings from own research.
8 scheduled presentations per year (posted here on DSFE’s homepage). Each session lasts 45 minutes and covers one specific paper and one theoretical topic. The theoretical presentation will constitute no more than 10 minutes and cover an issue related to the paper but presented in its own right, e.g. surveillance bias, propensity score adjustment, or reverse causation. The presentation of the paper focuses on the methods applied and the analytical choices made during the project (and their underlying rationale). The aim is to give a pragmatic walkthrough to highlight the practical issues faced, more so than the overarching methodology or clinical area of interest. The paper presentation takes no more than 25 minutes, which leaves 10 minutes for questions from attendees.
How to participate
Access the meeting room here.
We recommend testing the setup prior to the meeting by accessing the above link and clicking “Go to test site”.
All mics of participants will be muted centrally. In case of questions (during the last 10 minutes), please mark “raise your hand” and your mic will be centrally unmuted.
End of each month at 9.00 (only September-November and January-May)
|Date||Presenter||Paper||Theoretical topic||Link to previous presentations|
|Jun 27 2019||Thomas Ahern||Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study||Old school inferential paradigms - why reviewers are not always right||Recording
|May 2019||Anton Pottegård||Dr. Med.Sci dissertation defence||Pharmacoepidemiological assessment of drug-cancer associations||Recording
|May 1 2019||Kasper Adelborg||Use of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort study||New-user active comparator cohort studies||Recording
|Mar 2019||Henrik Støvring||Dr. Med.Sci dissertation defence||Using prescription data as indicators of disease or drug use, new analytic methods based on renewal processes||Recording
|Mar 27 2019||Morten Schmidt||Diclofenac use and cardiovascular risks: series of nationwide|
|Diclofenac and cardiovascular risks||Recording
|Feb 28||Marie Hargreave||Maternal use of fertility drugs and risk of cancer in children—A nationwide population‐based cohort study in Denmark||Seperating effects of the treatment from the underlying disease||Recording
|Jan 30 2019||Ellen Løkkegaard||Using prescription registries to define continuous drug use: how to fill gaps between prescriptions.|
Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleeding.
|Conditioning on the future in pharmacoepidemiology||Recording
|Oct 26 2018||Anton Pottegård||Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.||Exposure ascertainment in cancer studies||Recording
|Sep 28 2018||Lina Steinrud Mørch||Association of Hormonal Contraception With Suicide Attempts and Suicides||Surveillance and healthy user bias||Recording|
|May 2016||Lotte Rasmussen||Validity of the Prescriber Information in the Danish National Prescription Registry||validity of the prescriber information recorded in the Danish National Prescription Registry||Recording|
|April 2016||Michael Busch-Sørensen||‘Real World Data’, Usual practice, confounding og randomization is a current discussed mixture||Recording|
|Feb 2016||Jennifer Lund & Bradley Layton||Propensity score methods for confounding control in nonexperimental research||Propensity score methods: An introduction to Concepts and analysis||Recording|
|Jan 2016||Daniel Pilsgaard Henriksen||Comparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use--A Descriptive Cross-Sectional Study.||Recording|
|May 2015||Jesper Hallas & Henrik Toft Sørensen||Danish pharmacoepidemiology the past 25 years||Recording|